Showing results (181-190 of 213) with videos related to
Sort By:
Pageof 22
Science Translational Medicine|June 19, 2015
Transglutaminase 4 as a prostate autoantigen in male subfertilityNils Landegren, Donald Sharon, Anthony K Shum, et al.The Journal of Clinical Investigation|December 12, 2018
Tumor-conditional anti-CTLA4 uncouples antitumor efficacy from immunotherapy-related toxicityChien-Chun Steven Pai, Donald M Simons, Xiaoqing Lu, et al.Journal of Translational Medicine|July 19, 2026
Lyophilized platelet derived extracellular vesicles promote hemostasis and attenuate intracranial hemorrhage following traumatic brain injuryAlpa Trivedi, Byron Miyazawa, Alexander T Fields, et al.Journal for Immunotherapy of Cancer|February 20, 2021
Phase I study of ABBV-428, a mesothelin-CD40 bispecific, in patients with advanced solid tumorsJason J Luke, Fabrice Barlesi, Ki Chung, et al.Frontiers in Oncology|March 24, 2022
APOBEC Mutational Signature and Tumor Mutational Burden as Predictors of Clinical Outcomes and Treatment Response in Patients With Advanced Urothelial CancerDivya Natesan, Li Zhang, Henry J Martell, et al.JAMA Oncology|June 3, 2019
Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer-A Phase 1 StudyThomas S Uldrick, Priscila H Gonçalves, Maher Abdul-Hay, et al.European Urology|March 8, 2021
Efficacy and Safety of Atezolizumab Plus Bevacizumab Following Disease Progression on Atezolizumab or Sunitinib Monotherapy in Patients with Metastatic Renal Cell Carcinoma in IMmotion150: A Randomized Phase 2 Clinical TrialThomas Powles, Michael B Atkins, Bernard Escudier, et al.Journal for Immunotherapy of Cancer|June 20, 2020
Cancer Moonshot Immuno-Oncology Translational Network (IOTN): accelerating the clinical translation of basic discoveries for improving immunotherapy and immunoprevention of cancerAnanth Annapragada, Andrew Sikora, Catherine Bollard, et al.Bioconjugate Chemistry|November 11, 2017
Imaging PD-L1 Expression with ImmunoPETCharles Truillet, Hsueh Ling J Oh, Siok Ping Yeo, et al.Clinical Genitourinary Cancer|June 14, 2023
Impact of Squamous Histology on Clinical Outcomes and Molecular Profiling in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors or Enfortumab VedotinTanya Jindal, Li Zhang, Prianka Deshmukh, et al.Pageof 22